Heart Transplants
Findings from University Hospital advance knowledge in heart transplants
Published in Immunotherapy Weekly, January 12th, 2011
2011 JAN 12 -- New research, 'Reduced levels of both circulating CD4+ CD25+ CD127(low/neg) and CD4+ CD8(neg) invariant natural killer regulatory T cells in stable heart transplant recipients,' is the subject of a report. According to recent research from France, "A cross-regulation between two regulatory T cell (T(reg) ) subsets [CD4(+) CD25(+) and invariant natural killer (NK) T -iNK T] has been described to be important for allograft tolerance induction. However, few studies have evaluated these cellular subsets in stable recipients as correlates of favourable clinical outcome after heart transplantation."
"T(reg) and iNK T cell levels were assayed by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2011-01-12)
More Articles from Immunotherapy Weekly
- Systemic Lupus Erythematosus
New systemic lupus erythematosus research from Charite University outlined - Asthma
Reports summarize asthma research from G. Liccardi and co-authors - Obstetrics
Data from P.J. Stahl and colleagues advance knowledge in obstetrics - Chagas Disease
Federal University of Minas Gerais details research in Chagas disease - Experimental Immunology
Findings from University of Kentucky in experimental immunology reported - Endotoxins
Findings from University of Milan in endotoxins reported - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
